Prevalence of systemic sclerosis in a French multi-ethnic county

Rheumatology

Volumn 43, Issue 9, 2004, Pages 1129-1137

  Le Guern, V ^b   Mahr, Alfred ^b   Mouthon, L ^b   Jeanneret, D ^a   Carzon, M ^a   Guillevin, L ^b  

^a Caisse Nationale d'Assurance Maladie des Travailleurs Salaries   (France)

^b AVICENNE HOSPITAL   (France)

Author keywords

Capture recapture analysis; Epidemiology; Ethnicity; Prevalence; Systemic sclerosis

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; ETHNIC DIFFERENCE; ETHNOLOGY; FEMALE; FRANCE; GEOGRAPHIC DISTRIBUTION; GROUPS BY AGE; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; POPULATION DISTRIBUTION; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SEX DIFFERENCE; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; SYSTEMIC SCLEROSIS;

ADULT; AFRICA; AGE DISTRIBUTION; ASIA; AUTOANTIBODIES; CENTROMERE; FEMALE; HUMANS; MALE; MIDDLE AGED; PARIS; POPULATION SURVEILLANCE; PREVALENCE; SCLERODERMA, DIFFUSE; SCLERODERMA, LIMITED; SCLERODERMA, SYSTEMIC; URBAN HEALTH;

EID: 4544304953     PISSN: 14620324     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/keh253     Document Type: Article

References (46)

1. Medsger TA Jr, Masi AT, Rodnan GP, Benedek TG, Robinson H. Survival with systemic sclerosis (scleroderma). A life-table analysis of clinical and demographic factors in 309 patients. Ann Intern Med 1971;75:369-76.
2. Giordano M, Valentini G, Migliaresi S, Picillo U, Vatti M. Different antibody patterns and different prognoses in patients with scleroderma with various extent of skin sclerosis. J Rheumatol 1986;13:911-16.
3. Barnett AJ, Miller MH, Littlejohn GO. A survival study of patients with scleroderma diagnosed over 30 years (1953-1983): the value of a simple cutaneous classification in the early stages of the disease. J Rheumatol 1988;15:276-83.
4. Silman AJ. Epidemiology of scleroderma. Curr Opin Rheumatol 1991;3:967-72.
5. Mayes MD. Scleroderma epidemiology. Rheum Dis Clin North Am 1996;22:751-64.
6. Roberts-Thomson PJ, Jones M, Hakendorf P et al. Scleroderma in South Australia: epidemiological observations of possible pathogenic significance. Int Med J 2001;31:220-9.
7. Silman A, Jannini S, Symmons D, Bacon P. An epidemiological study of scleroderma in the West Midlands. Br J Rheumatol 1988; 27:286-90.
8. Shinkai H. Epidemiology of progressive systemic sclerosis in Japan. In: Black CM, Myers AR (eds). Progressive Systemic Sclerosis (Current Topics in Rheumatology). New York: Gower, 1985:79-81.
9. Mayes MD, Lacey JV Jr, Beebe-Dimmer J et al. Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population. Arthritis Rheum 2003;48:2246-55.
10. Tamaki T, Mori S, Takehara K. Epidemiological study of patients with systemic sclerosis in Tokyo. Arch Dermatol Res 1991; 283:366-71.
11. Thompson AE, Pope JE. Increased prevalence of scleroderma in southwestern Ontario: a cluster analysis. J Rheumatol 2002; 29:1867-73.
12. Valter I, Saretok S, Maricq HR. Prevalence of scleroderma spectrum disorders in the general population of Estonia. Scand J Rheumatol 1997;26:419-25.
13. Asboe-Hansen G. Epidemiology of progressive systemic sclerosis in Denmark. In: Black CM, Myers AR (eds). Progressive Systemic Sclerosis (Current Topics in Rheumatology). New York: Gower, 1985:78.
14. Chandran G, Smith M, Ahern MJ, Roberts-Thomson PJ. A study of scleroderma in South Australia: prevalence, subset characteristics and nailfold capillaroscopy. Aust NZ J Med 1995;25:688-94.
15. Englert H, Small-McMahon J, Davis K, O'Connor H, Chambers P, Brooks P. Systemic sclerosis prevalence and mortality in Sydney 1974-88. Aust NZ J Med 1999;29:42-50.
16. Geirsson AJ, Steinsson K, Guthmundsson S, Sigurthsson V. Systemic sclerosis in Iceland. A nationwide epidemiological study. Ann Rheum Dis 1994;53:502-5.
17. Giordano M. Epidemiology of progressive systemic sclerosis in Italy. In: Black CM, Myers AR (eds). Progressive Systemic Sclerosis (Current Topics in Rheumatology). New York: Gower, 1985:72-7.
18. Haustein UF, Ziegler V, Zchunke E, Munzberger H, Kopping H. Progressive systemic sclerosis with silicosis in the German Democratic Republic. In: Black CM, Myers AR (eds). Progressive Systemic Sclerosis (Current Topics in Rheumatology). New York: Gower, 1985:138-41.
19. Maricq HR, Weinrich MC, Keil JE et al. Prevalence of scleroderma spectrum disorders in the general population of South Carolina. Arthritis Rheum 1989;32:998-1006.
20. Michet CJ Jr, McKenna CH, Elveback LR, Kaslow RA, Kurland LT. Epidemiology of systemic lupus erythematosus and other connective tissue diseases in Rochester, Minnesota, 1950 through 1979. Mayo Clin Proc 1985;60:105-13.
21. Kuwana M, Kaburaki J, Arnett FC, Howard RF, Medsger TA Jr, Wright TM. Influence of ethnic background on clinical and serologic features in patients with systemic sclerosis and anti-DNA topoisomerase I antibody. Arthritis Rheum 1999;42:465-74.
22. Kuwana M, Okano Y, Kaburaki J, Tojo T, Medsger TA Jr. Racial differences in the distribution of systemic sclerosis-related serum antinuclear antibodies. Arthritis Rheum 1994;37:902-6.
23. Laing TJ, Gillespie BW, Toth MB et al. Racial differences in scleroderma among women in Michigan. Arthritis Rheum 1997; 40:734-42.
24. McNeilage LJ, Youngchaiyud U, Whittingham S. Racial differences in antinuclear antibody patterns and clinical manifestations of scleroderma. Arthritis Rheum 1989;32:54-60.
25. Greidinger EL, Flaherty KT, White B, Rosen A, Wigley FM, Wise RA. African-American race and antibodies to topoisomerase I are associated with increased severity of scleroderma lung disease. Chest 1998;114:801-7.
26. Reveille JD, Durban E, Goldstein R, Moreda R, Arnett FC. Racial differences in the frequencies of scleroderma-related autoantibodies. Arthritis Rheum 1992;35:216-18.
27. Reveille JD, Fischbach M, McNearney T et al. Systemic sclerosis in 3 US ethnic groups: a comparison of clinical, sociodemographic, serologic, and immunogenetic determinants. Semin Arthritis Rheum 2001;30:332-46.
28. Steen VD, Oddis CV, Conte CG, Janoski J, Casterline GZ, Medsger TA Jr. Incidence of systemic sclerosis in Allegheny County, Pennsylvania. A twenty-year study of hospital-diagnosed cases, 1963-1982. Arthritis Rheum 1997;40:441-5.
29. Mahr A, Guillevin L, Poissonnet M, Aymé S. Prevlence of polyarteritis nodosa, microscopic polyangiitis, Wegener's granulomatosis and Churg-Strauss syndrome in a French urban population in 2000: a capture-recapture estimate. Arthritis Rheum 2004;51: 92-9.
30. Blin F, Denais MC. Institut National des Statistiques et des Etudes Economiques: Gros Plan sur l'Emploi Francilien en 1999; 2001.
31. Recensement de la Population de 1999. Tableaux, références et analyses - exploitation principale: Seine-Saint-Denis. Institut National des Statistiques et des Etudes Economiques; 2000.
32. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum 1980;23:581-90.
33. LeRoy EC, Medsger TA Jr. Criteria for the classification of early systemic sclerosis. J Rheumatol 2001;28:1573-6.
34. McCarty DJ, Manzi S, Medsger TA Jr, Ramsey-Goldman R, LaPorte RE, Kwoh CK. Incidence of systemic lupus erythematosus. Race and gender differences. Arthritis Rheum 1995;38:1260-70.
35. Bishop YMM, Fienberg SE, Holland PW. Discrete Multivariate Analysis: Theory and Practice. Cambridge, MA, 1975.
36. Cormack R. The statistics of capture-recapture methods. Oceanogr Mar Biol Ann Rev 1968;6:455-506.
37. Draper D. Assessment and propagation of model uncertainty. J R Statist Soc 1995;57:45-70.
38. Gallay A, Vaillant V, Bouvet P, Grimont P, Desenclos JC. How many foodborne outbreaks of Salmonella infection occurred in France in 1995? Application of the capture-recapture method to three surveillance systems. Am J Epidemiol 2000;152:171-7.
39. Hook EB, Regal RR. Capture-recapture methods in epidemiology: methods and limitations. Epidemiol Rev 1995;17:243-64.
40. Lonzetti LS, Joyal F, Raynauld JP et al. Updating the American College of Rheumatology preliminary classification criteria for systemic sclerosis: addition of severe nailfold capillaroscopy abnormalities markedly increases the sensitivity for limited scleroderma. Arthritis Rheum 2001;44:735-6.
41. Medsger TA Jr. Comment on Scleroderma Criteria Cooperative Study. In: Black CM, Myers AR (eds). Progressive Systemic Sclerosis (Current Topics in Rheumatology). New York: Gower, 1985:16-17.
42. Poormoghim H, Lucas M, Fertig N, Medsger TA, Jr. Systemic sclerosis sine scleroderma: demographic, clinical, and serologic features, and survival in forty-eight patients. Arthritis Rheum 2000;43:444-51.
43. Scussel-Lonzetti L, Joyal F, Raynauld JP et al. Predicting mortality in systemic sclerosis: analysis of a cohort of 309 French Canadian patients with emphasis on features at diagnosis as predictive factors for survival. Medicine (Baltimore) 2002;81:154-67.
44. Wigley FM. When is scleroderma really scleroderma? J Rheumatol 2001;28:1471-3.
45. Reveille JD. Ethnicity and race and systemic sclerosis: how it affects susceptibility, severity, antibody genetics, and clinical manifestations. Curr Rheumatol Rep 2003;5:160-7.
46. Arnett FC, Howard RE, Tan F et al. Increased prevalence of systemic sclerosis in a Native American tribe in Oklahoma. Association with an Amerindian HLA haplotype. Arthritis Rheum 1996;39:1362-70.